TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28631989

Group type: EXPERIMENTAL
Intervention: High rapport condition
Number of subjects: 98

Group type: COMPARATOR
Intervention: Low rapport condition
Number of subjects: 98
Study: 28068165

Group type: COMPARATOR
Intervention: Head Cooling (HC)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Forearm Cooling (FC)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control
Number of subjects: 27
Study: 24243632

Group type: EXPERIMENTAL
Intervention: Moderate Intensity Exercise (MIE)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High Intensity Exercise (HIE)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (1 hour of seated rest)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Comparison between MIE and HIE
Number of subjects: 18
Study: 25534331

Group type: EXPERIMENTAL
Intervention: TAP block (Group 1, n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No TAP block (Group 2, n=20)
Number of subjects: 40
Study: 22925365

Group type: EXPERIMENTAL
Intervention: Electrosurgical bipolar vessel sealing
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional clamping and suturing
Number of subjects: 100
Study: 20655660

Group type: EXPERIMENTAL
Intervention: Chinese acupuncture (verum)
Number of subjects: 424

Group type: COMPARATOR
Intervention: Sham acupuncture (sham)
Number of subjects: 424

Group type: COMPARATOR
Intervention: Conventional conservative orthopaedic treatment (COT)
Number of subjects: 424
Study: 17717682

Group type: EXPERIMENTAL
Intervention: Alcohol in juice (1.4 g/l)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Juice (placebo)
Number of subjects: 19
Study: 15758565

Group type: EXPERIMENTAL
Intervention: 4 mg intravenous dexamethasone suppression test
Number of subjects: 31
Study: 12036821

Group type: EXPERIMENTAL
Intervention: Calcium (1450 mg/d) and vitamin D (10 microg (400 IU)/d)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Calcium, vitamin D, and other nutrients (multinutrient supplement)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Dietary instruction (dietary control group)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 99
Study: 10208191

Group type: EXPERIMENTAL
Intervention: Albuterol via Clickhaler (DPI) at 200 microg inhaled at 15 L/min
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Albuterol via Clickhaler (DPI) at 200 microg inhaled at 30 L/min
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Albuterol via Clickhaler (DPI) at 200 microg inhaled at 60 L/min
Number of subjects: 16

Group type: COMPARATOR
Intervention: Albuterol via pMDI inhaled at 30 L/min
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 8674265

Group type: EXPERIMENTAL
Intervention: Computer-based exercise test analyzer
Number of subjects: 60
Study: 1844749

Group type: EXPERIMENTAL
Intervention: Diuretics alone (23%)
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Beta blockers alone (32%)
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Diuretic and beta blocker (38%)
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Combined therapy with vasodilators (9%)
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Other forms of therapy (5%)
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 714
Study: 6301804

Group type: EXPERIMENTAL
Intervention: Renitidin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Gastrozepin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31428433

Group type: EXPERIMENTAL
Intervention: Behaviour change intervention (delivered over eight sessions as weekly one‐on‐one, face‐to‐face 40‐min consultations)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Usual care (pharmacological treatment and similar educational programmes)
Number of subjects: 55
Study: 29134635

Group type: EXPERIMENTAL
Intervention: Ribociclib
Number of subjects: 0
Study: 29871085

Group type: EXPERIMENTAL
Intervention: Canalith repositioning (Barbecue reposition maneuver)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Reposition plus drug treatment (Barbecue reposition maneuver + Alprostadil, Cinepazide, Betahistine)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Canalith repositioning
Number of subjects: 62

Group type: COMPARATOR
Intervention: Reposition plus drug treatment
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study: 25730940

Group type: EXPERIMENTAL
Intervention: GC Fuji IX GP
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GC Fuji IX GP EXTRA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GC EQUIA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GC Coat - EQUIA (light curing varnish)
Number of subjects: 30
Study: 22196577

Group type: EXPERIMENTAL
Intervention: Lavender oil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual hospital protocol (Control)
Number of subjects: 60
Study: 20854342

Group type: EXPERIMENTAL
Intervention: Foot massage (20 min daily for 5 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (standard prenatal care)
Number of subjects: 80
Study: 17983871

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension 0.5 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Montelukast 4 or 5 mg once daily
Number of subjects: 0
Study: 16027500

Group type: EXPERIMENTAL
Intervention: Hand-Acupuncture therapy for 20 minutes
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (resting on the bed)
Number of subjects: 40
Study: 12492272

Group type: EXPERIMENTAL
Intervention: Ankle brace
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ankle tape
Number of subjects: 14

Group type: COMPARATOR
Intervention: No stabilizer (control)
Number of subjects: 14
Study: 10681792

Group type: EXPERIMENTAL
Intervention: Myocardial ischemic preconditioning (Group IP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 20
Study: 9183983

Group type: EXPERIMENTAL
Intervention: Oxazepam
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control session
Number of subjects: 13
Study: 1380411

Group type: EXPERIMENTAL
Intervention: Epoetin beta, 250 U/kg
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Epoetin beta, 500 U/kg
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Epoetin beta, 1000 U/kg
Number of subjects: 87

Group type: COMPARATOR
Intervention: Intravenous placebo
Number of subjects: 87
Study: 6873004

Group type: EXPERIMENTAL
Intervention: Social alcohol intake (1-3 glasses of vodka mixed with orangeade, consumed twice a week for 16 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social alcohol intake
Number of subjects: 0
Study: 31745051

Group type: EXPERIMENTAL
Intervention: Group II - purple-coated TMA archwires
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Group III - honey dew-coated TMA wires
Number of subjects: 63

Group type: COMPARATOR
Intervention: Group I - regular TMA archwires
Number of subjects: 63
Study: 29725798

Group type: COMPARATOR
Intervention: Supportive therapy group
Number of subjects: 39

Group type: COMPARATOR
Intervention: Exercise group
Number of subjects: 39
Study: 26937930

Group type: EXPERIMENTAL
Intervention: Foraminoplasty via upper border of inferior pedicle (Group A)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Common transforaminal route (Group B)
Number of subjects: 45
Study: 24719139

Group type: EXPERIMENTAL
Intervention: ALN/D5600 (alendronate 70 mg + 5600 IU vitamin D₃)
Number of subjects: 268

Group type: COMPARATOR
Intervention: ALN (alendronate 70 mg without additional vitamin D)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: ALN/D5600
Number of subjects: 268

Group type: COMPARATOR
Intervention: ALN
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: ALN/D5600 and ALN
Number of subjects: 268
Study: 23767196

Group type: EXPERIMENTAL
Intervention: Octreotide (100 microgram stat) along with fluid and antibiotics
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Racecadotril (1.5 mg/kg three times a day) along with fluid and antibiotics
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group received only fluids and antibiotics
Number of subjects: 150
Study: 19395036

Group type: EXPERIMENTAL
Intervention: Preoperative diagnosis of pseudophakic or aphakic corneal edema
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Prior glaucoma surgery with preoperative glaucoma medication use
Number of subjects: 1090

Group type: COMPARATOR
Intervention: Age, gender, diabetes, smoking, and graft size
Number of subjects: 1090
Study: 17848840

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII) with aspart or lispro insulin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Multiple daily injections (MDI) with once-daily glargine and human regular insulin at meals
Number of subjects: 36
Study: 15854937

Group type: COMPARATOR
Intervention: On-pump surgery
Number of subjects: 120

Group type: COMPARATOR
Intervention: Off-pump surgery
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study: 11952586

Group type: EXPERIMENTAL
Intervention: Multimodal rehabilitation (group 2)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional care (group 1)
Number of subjects: 28
Study: 9862252

Group type: EXPERIMENTAL
Intervention: Irbesartan 25 mg capsules (two capsules after a 10 h fast)
Number of subjects: 48
Study: 7650233

Group type: EXPERIMENTAL
Intervention: Td vaccine alone (group 1)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Td vaccine plus 500 IU of TIG (group 2)
Number of subjects: 119
Study: 2792781

Group type: EXPERIMENTAL
Intervention: Exercise program (12-week, 36 classes)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 805518

Group type: EXPERIMENTAL
Intervention: Fortified maize
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fortified rice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fortified bread
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aqueous solution of pteroylglutamic acid
Number of subjects: 0
Study: 31758324

Group type: EXPERIMENTAL
Intervention: Nutrition intervention (n = 92)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard care (n = 88)
Number of subjects: 180
Study: 31184639

Group type: EXPERIMENTAL
Intervention: Milled bar overdentures
Number of subjects: 36

Group type: COMPARATOR
Intervention: Ceramo-metal fixed prostheses
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups (milled bar overdentures and fixed prostheses)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Fixed prostheses
Number of subjects: 36
Study: 28709650

Group type: EXPERIMENTAL
Intervention: Enoxaparin-warfarin
Number of subjects: 2199
Study: 25956739

Group type: EXPERIMENTAL
Intervention: Unlinked, modular bicompartmental arthroplasty (BCA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 48
Study: 22672107

Group type: EXPERIMENTAL
Intervention: Cilostazol (100 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (Aspirin 100 mg or Clopidogrel 50 mg‐75 mg daily)
Number of subjects: 20
Study: 21663422

Group type: EXPERIMENTAL
Intervention: Lithium 300 mg twice daily (Arm I)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Lithium 300 mg thrice daily (Arms II and III)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Lithium treatment (all arms)
Number of subjects: 61
Study: 20178287

Group type: EXPERIMENTAL
Intervention: Accurate feedback
Number of subjects: 63

Group type: COMPARATOR
Intervention: False feedback
Number of subjects: 63
Study: 16965240

Group type: COMPARATOR
Intervention: Control
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Low fat (15% of energy)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: High fruit and vegetable (9 servings per day)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Combination low fat, high FV
Number of subjects: 122
Study: 15861964

Group type: EXPERIMENTAL
Intervention: Rehabilitation and shoulder exercises program according to Bobath
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rehabilitation only
Number of subjects: 20
Study: 11151749

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 250 mg twice daily for 7 days
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 9291904

Group type: EXPERIMENTAL
Intervention: Early amniocentesis
Number of subjects: 1160

Group type: COMPARATOR
Intervention: Chorionic villus sampling (CVS)
Number of subjects: 1160
Study: 8378121

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 84

Group type: COMPARATOR
Intervention: Nylidrin
Number of subjects: 84
Study: 3704451

Group type: EXPERIMENTAL
Intervention: Methylphenidate (10, 30, or 60 mg/day)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pemoline (18.75, 56.25, or 112.5 mg/day)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Protriptyline (10, 30, or 60 mg/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 17
Study: 28832089

Group type: EXPERIMENTAL
Intervention: Cleft lip and palate patients (study group)
Number of subjects: 54

Group type: COMPARATOR
Intervention: General population patients (control group)
Number of subjects: 54
Study: 27453375

Group type: EXPERIMENTAL
Intervention: Weight management intervention through a randomized clinical trial (RCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reasons for declining referral
Number of subjects: 0
Study: 25005346

Group type: EXPERIMENTAL
Intervention: Fixed Tc-99m-tetrofosmin tracer dose
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Body weight-dependent tracer dose and scan time
Number of subjects: 125
Study: 21495052

Group type: EXPERIMENTAL
Intervention: Behavioral family therapy (BFT) plus fluoxetine
Number of subjects: 160

Group type: COMPARATOR
Intervention: Behavioral family therapy (BFT) plus placebo
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Systems family therapy (SFT) plus fluoxetine
Number of subjects: 160

Group type: COMPARATOR
Intervention: Systems family therapy (SFT) plus placebo
Number of subjects: 160
Study: 20362843

Group type: EXPERIMENTAL
Intervention: View-in test
Number of subjects: 78

Group type: COMPARATOR
Intervention: Wall-chart test
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Cataract patients preoperative
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Cataract patients postoperative
Number of subjects: 78
Study: 18978102

Group type: EXPERIMENTAL
Intervention: Mifepristone 10 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mifepristone 5 mg
Number of subjects: 100
Study: 16024863

Group type: EXPERIMENTAL
Intervention: 12 Gy external beam radiotherapy (EBRT) delivered as 6 x 2 Gy fractions to the macula of an affected eye
Number of subjects: 199

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 199
Study: 12070572

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 2940

Group type: COMPARATOR
Intervention: Control (any other anti-hypertensive)
Number of subjects: 2940
Study: 10336033

Group type: EXPERIMENTAL
Intervention: PRK
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: LASIK
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: ICRS
Number of subjects: 31
Study: 8984147

Group type: EXPERIMENTAL
Intervention: Troxerutin 3,500 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Troxerutin 1,000 mg twice daily
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 9
Study: 1837496

Group type: COMPARATOR
Intervention: Acute verapamil administration (160 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chronic verapamil treatment (240 mg/day for 12 months)
Number of subjects: 12
Study: 6122652

Group type: EXPERIMENTAL
Intervention: 1 mg flunitrazepam orally the night before operation and 1 mg on the morning of operation (group 1)
Number of subjects: 41

Group type: COMPARATOR
Intervention: 100 mg pentobarbital orally the night before operation, followed by intramuscular scopolamine (0.006 mg/kg) + morphine (0.02 mg/kg) on the morning of operation (group 2)
Number of subjects: 41
Study: 30979659

Group type: EXPERIMENTAL
Intervention: Walnut consumption (2 oz per day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no walnut consumption)
Number of subjects: 10
Study: 28844361

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive therapy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Counseling as standard care
Number of subjects: 200
Study: 25543999

Group type: EXPERIMENTAL
Intervention: Thoracic high velocity low amplitude thrust manipulations (HVLATM) to the thoracic spine
Number of subjects: 43
Study: 22534819

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (sugar pill)
Number of subjects: 33
Study: 21371164

Group type: EXPERIMENTAL
Intervention: Formulated Collagen Gel (FCG)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Ad5PDGF‐B (GAM501)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 124
Study: 19835120

Group type: EXPERIMENTAL
Intervention: Medicinal moxa stick moxibustion (MMS)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Moxa stick moxibustion (MS)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Nitramisole cream (NC)
Number of subjects: 144
Study: 17907004

Group type: EXPERIMENTAL
Intervention: Micronized estradiol 2 mg/day
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Micronized estradiol 2 mg/day plus norethisterone acetate 1 mg/day
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 15860489

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 12040360

Group type: EXPERIMENTAL
Intervention: Terbogrel (thromboxane synthetase inhibitor and receptor antagonist) for 12 weeks
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 9873846

Group type: EXPERIMENTAL
Intervention: Asserachrom VIII:CAg ELISA using monoclonal antibodies (MoAbs 833 and D4H1)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Asserachrom VIII:CAg ELISA
Number of subjects: 294
Study: 8848535

Group type: EXPERIMENTAL
Intervention: Lorazepam (1.2 mg)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 2365604

Group type: EXPERIMENTAL
Intervention: Education (E) alone consisting of a brief lecture on AIDS
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Enhanced education (EE) with a lecture and videotape on condom use
Number of subjects: 75

Group type: COMPARATOR
Intervention: Controls (C) receiving no education
Number of subjects: 75
Study: 688767

Group type: EXPERIMENTAL
Intervention: Ultramicrosize griseofulvin (Gris-PEG)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Topical clotrimazole (Lotrimin)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Combination of ultramicrosize griseofulvin and topical clotrimazole
Number of subjects: 73
Study: 30314724

Group type: EXPERIMENTAL
Intervention: Lateral lymph node dissection
Number of subjects: 445

Group type: COMPARATOR
Intervention: Non-lateral lymph node dissection
Number of subjects: 445
Study: 28694345

Group type: EXPERIMENTAL
Intervention: Link online mental health help-seeking navigation tool
Number of subjects: 51

Group type: COMPARATOR
Intervention: Usual help-seeking strategies with a link to Google.com
Number of subjects: 51
Study: 25994853

Group type: EXPERIMENTAL
Intervention: Erlotinib administered 2 hours after a meal
Number of subjects: 23

Group type: COMPARATOR
Intervention: Erlotinib administered in complete fasting
Number of subjects: 23
Study: 24152604

Group type: EXPERIMENTAL
Intervention: 25 mg empagliflozin under fasted conditions
Number of subjects: 18

Group type: COMPARATOR
Intervention: 25 mg empagliflozin after a high‐fat, high‐calorie breakfast
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10 mg empagliflozin under fasted conditions
Number of subjects: 18
Study: 21781598

Group type: EXPERIMENTAL
Intervention: Video-assisted minimally invasive radiofrequency ablation (MIA)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Catheter ablation (CA)
Number of subjects: 172
Study: 19641522

Group type: EXPERIMENTAL
Intervention: MRD flow
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: RQ-PCR
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: MRD flow and PCR
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: PCR
Number of subjects: 69
Study: 17848854

Group type: EXPERIMENTAL
Intervention: $7 financial incentive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: $14 financial incentive
Number of subjects: 0

Group type: COMPARATOR
Intervention: No financial incentive
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Equalized financial gains across groups
Number of subjects: 0
Study: 14969628

Group type: EXPERIMENTAL
Intervention: Carbon-coated stents (CC)
Number of subjects: 347

Group type: COMPARATOR
Intervention: Stainless steel stents (SS)
Number of subjects: 347
Study: 11355930

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage (GM)-CSF or Granulocyte (G)-CSF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytokines (CSFs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytokines (e.g. pegylated recombinant human megakaryocytic growth and development factor + G- or GM-CSF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapies targeting cytokine receptors on AML blasts
Number of subjects: 0
Study: 9153103

Group type: EXPERIMENTAL
Intervention: EPO administration (120 U/kg per week for 5 to 8 months)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no EPO treatment)
Number of subjects: 50
Study: 7899040

Group type: EXPERIMENTAL
Intervention: Horizontal shearing motion with lateral head movement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stimulus producing MAE
Number of subjects: 0
Study: 3584749

Group type: EXPERIMENTAL
Intervention: Fractionated IgG (10 to 15 gm)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Active immunization with HBV
Number of subjects: 27
Study: 29673375

Group type: EXPERIMENTAL
Intervention: Health Potential® service (PHC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Additional lifestyle counselling (part B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: General health check (GHC)
Number of subjects: 0